Brazil authorizes import of raw material to produce Chinese COVID-19 vaccine

[vi-va]

Reuters | Breaking International News & Views

Find latest news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

in.reuters.com

Brazil authorizes import of raw material to produce Chinese COVID-19 vaccine
By Reuters Staff
1 MIN READ

BRASILIA, Oct 28 (Reuters) - Brazil’s health regulator Anvisa said on Wednesday it has authorized the import of raw materials from Chinese company Sinovac for the production of its COVID-19 vaccine.
Sao Paulo’s biomedical institute Butantan plans to produce the vaccine. (Reporting by Ricardo Brito, writing by Stephen Eisenhammer, editing by Chris Reese)